Mega Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 5.25 M
as on 16-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 28.84%
(FY 2023)
- Profit 45.63%
(FY 2023)
- Ebitda 118.59%
(FY 2023)
- Net Worth 4.25%
(FY 2023)
- Total Assets 11.34%
(FY 2023)
About Mega Lifesciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.25 M, as per Ministry of Corporate Affairs (MCA) records.
Laxman Mahadik, Vivek Dhawan, and Thomas Abraham serve as directors at the Company.
- CIN/LLPIN
U24231MH2004PTC150368
- Company No.
150368
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mega Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxman Mahadik  | Director | 01-Jun-2004 | Current |
Vivek Dhawan  | Director | 05-Apr-2004 | Current |
| Thomas Abraham | Director | 05-Apr-2004 | Current |
Financial Performance of Mega Lifesciences.
Mega Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.84% increase. The company also saw a substantial improvement in profitability, with a 45.63% increase in profit. The company's net worth moved up by a moderate rise of 4.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mega Lifesciences?
In 2023, Mega Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mega Lifesciences?
Unlock and access historical data on people associated with Mega Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mega Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mega Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
